Norathyriol suppresses transformation in JB6 P+ cells by the inhibition of Akt.
Li J, Li X, He Z, Zhou K.
J Cancer Res Ther · research support, non-u.s. gov't; journal article · DOI 10.4103/0973-1482.106537Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för norathyriol. Visa hela publikationsregistret
Li J, Li X, He Z, Zhou K.
J Cancer Res Ther · research support, non-u.s. gov't; journal article · DOI 10.4103/0973-1482.106537Li J, Malakhova M, Mottamal M, Reddy K, Kurinov I, Carper A, Langfald A, Oi N, Kim MO, Zhu F, Sosa CP, Zhou K, Bode AM, Dong Z.
Cancer Res · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1158/0008-5472.can-11-2596Chieli E, Romiti N, Rodeiro I, Garrido G.
Chem Biol Interact · journal article · DOI 10.1016/j.cbi.2010.05.012Don MJ, Huang YJ, Huang RL, Lin YL.
Chem Pharm Bull (Tokyo) · research support, non-u.s. gov't; journal article · DOI 10.1248/cpb.52.866Wang JP, Raung SL, Tsao LT, Lin CN.
Eur J Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(97)01214-4Wang JP, Raung SL, Lin CN, Teng CM.
Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/0014-2999(94)90440-5UENO A.
Yakugaku Zasshi · journal article